Product Overview
The DRI® Barbiturates (BAR) Toxicology Reagent is designed for use with the MedTest 200 Ensemble, 480 Ensemble, and 800 Ensemble Systems. This reagent is intended for the qualitative and quantitative determination of barbiturates in human urine specimens. It provides accurate, fast, and reliable results in clinical toxicology testing, allowing for the effective detection of barbiturates, a class of sedative-hypnotic drugs commonly used for their calming effects but also associated with overdose risk.
Product Features
- The DRI® Barbiturates Reagent is highly sensitive to the presence of barbiturates in urine, providing reliable and specific results.
- It is designed for use with the MedTest 200, 480, and 800 Ensemble Systems, offering a seamless integration with these automated systems for high-throughput testing in clinical laboratories.
- The reagent allows for quick analysis and is designed to reduce the time from sample collection to result reporting, enabling faster clinical decision-making.
- It provides a broad detection range for barbiturates, making it suitable for a variety of testing needs.
- As part of the DRI® (Direct Reagent Immunoassay) series, it ensures high-quality, accurate results with minimal interference from other substances.
Product Specifications
| Catalog Number/SKU | MF-5390012246 |
| Application | Toxicology Reagent |
|---|---|
| For Use With | For MedTest 200 Ensemble, 480 Ensemble and 800 Ensemble Systems |
| Form | Liquid |
| Sample Type | Urine Sample |
| Specialty | Toxicology |
| Storage Requirements | Requires Refrigeration |
| Test Category | Drugs of Abuse |
| Test Name | Barbiturates (BAR) |
| Test Type | Single Drug |
| Volume | 2 X 100 mL |
